Herceptin (generic name, trastuzumab) is a new drug used to treat some women with advanced breast cancer whose cancer has spread to other areas of the body. Approved for use by the U.S. Food and Drug Administration (FDA) in September 1998, Herceptin has shown great promise in increasing patient survival time and reducing the number of deaths ...

A new drug to fight breast cancer is pointing the way toward the development of an entirely new type of weapon against cancers of all types.